TY - JOUR
T1 - Emulating a Target Trial of Interventions Initiated During Pregnancy with Healthcare Databases
T2 - The Example of COVID-19 Vaccination
AU - Hernández-Díaz, Sonia
AU - Huybrechts, Krista F.
AU - Chiu, Yu Han
AU - Yland, Jennifer J.
AU - Bateman, Brian T.
AU - Hernán, Miguel A.
N1 - Funding Information:
SHD reports being an investigator on grants to her institution from Takeda for unrelated studies; receiving personal fees as a consultant from UCB and Roche outside the submitted work; and having served as an epidemiologist with the North America AED pregnancy registry, which is funded by multiple companies. KFH reports being an investigator on research grants to Brigham and Women’s Hospital from Takeda and UCB for unrelated studies; and receiving personal fees from Syneos Health outside the submitted work. BTB reports receiving research grants to Brigham and Women’s Hospital from Eli Lilly, Baxalta, and Pacira for unrelated studies; receiving personal fees from Aetion and from Alosa Foundation outside the submitted work; and has served on an expert panel for a postpartum hemorrhage quality improvement project that was conducted by the Association of Women’s Health, Obstetric, and Neonatal Nurses and funded by a grant from Merck for Mothers. MAH reports being a consultant for Cytel and being an adviser for ProPublica. YHC and JJY report no conflicts of interest.
Funding Information:
This work was supported by National Institute of Child Health and Human Development Grant R01HD088393.
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Background: Observational studies are often the only option to estimate effects of interventions during pregnancy. Causal inference from observational data can be conceptualized as an attempt to emulate a hypothetical pragmatic randomized trial: the target trial. Objective: To provide a step-by-step description of how to use healthcare databases to estimate the effects of interventions initiated during pregnancy. As an example, we describe how to specify and emulate a target trial of COVID-19 vaccination during pregnancy, but the framework can be generally applied to point and sustained strategies involving both pharmacologic and non-pharmacologic interventions. Methods: First, we specify the protocol of a target trial to evaluate the safety and effectiveness of vaccination during pregnancy. Second, we describe how to use observational data to emulate each component of the protocol of the target trial. We propose different target trials for different gestational periods because the outcomes of interest vary by gestational age at exposure. We identify challenges that affect (i) the target trial and thus its observational emulation (censoring and competing events), and (ii) mostly the observational emulation (confounding, immortal time, and measurement biases). Conclusion: Some biases may be unavoidable in observational emulations, but others are avoidable. For instance, immortal time bias can be avoided by aligning the start of follow-up with the gestational age at the time of the intervention, as we would do in the target trial. Explicitly emulating target trials at different gestational ages can help reduce bias and improve the interpretability of effect estimates for interventions during pregnancy.
AB - Background: Observational studies are often the only option to estimate effects of interventions during pregnancy. Causal inference from observational data can be conceptualized as an attempt to emulate a hypothetical pragmatic randomized trial: the target trial. Objective: To provide a step-by-step description of how to use healthcare databases to estimate the effects of interventions initiated during pregnancy. As an example, we describe how to specify and emulate a target trial of COVID-19 vaccination during pregnancy, but the framework can be generally applied to point and sustained strategies involving both pharmacologic and non-pharmacologic interventions. Methods: First, we specify the protocol of a target trial to evaluate the safety and effectiveness of vaccination during pregnancy. Second, we describe how to use observational data to emulate each component of the protocol of the target trial. We propose different target trials for different gestational periods because the outcomes of interest vary by gestational age at exposure. We identify challenges that affect (i) the target trial and thus its observational emulation (censoring and competing events), and (ii) mostly the observational emulation (confounding, immortal time, and measurement biases). Conclusion: Some biases may be unavoidable in observational emulations, but others are avoidable. For instance, immortal time bias can be avoided by aligning the start of follow-up with the gestational age at the time of the intervention, as we would do in the target trial. Explicitly emulating target trials at different gestational ages can help reduce bias and improve the interpretability of effect estimates for interventions during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=85147186554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147186554&partnerID=8YFLogxK
U2 - 10.1097/EDE.0000000000001562
DO - 10.1097/EDE.0000000000001562
M3 - Article
C2 - 36722806
AN - SCOPUS:85147186554
SN - 1044-3983
VL - 34
SP - 238
EP - 246
JO - Epidemiology
JF - Epidemiology
IS - 2
ER -